DEF: Datavault AI Seeks Massive Share Increase, Scilex Deal

Datavault AI Inc. will hold its Annual Meeting to vote on electing directors, ratifying auditors, and significantly increasing authorized shares to facilitate a major equity issuance to Scilex Holding Company.

Summary

• Stockholders will vote on electing nine members to the Board of Directors.
• A proposal to ratify BPM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, will be considered.
• An amendment to the Certificate of Incorporation is proposed to increase authorized capital stock from 320,000,000 shares to 2,020,000,000 shares, with common stock increasing to 2,000,000,000 shares.
• Stockholder approval is sought for the issuance of 20% or more of outstanding common stock to Scilex Holding Company under a pre-funded warrant, as per a securities purchase agreement dated September 25, 2025.
• The pre-funded warrant to Scilex is exercisable for 263,914,094 shares of Common Stock at an exercise price of $0.0001 per share.
• The initial closing with Scilex involved the purchase of 15,000,000 shares of Common Stock for an aggregate purchase price of $150,000,000 in Bitcoin (BTC).

Sentiment

Score: 3

Explanation: The sentiment is largely negative due to the significantly widening net losses, the massive potential for shareholder dilution from the proposed share increase and the Scilex warrant, and the high cost of capital indicated by the large share issuance. While a capital raise provides liquidity, the terms and the underlying financial performance are concerning.

Positives

• Secured a significant capital infusion of $150,000,000 in Bitcoin (BTC) from Scilex Holding Company through an initial share purchase and a pre-funded warrant agreement, providing liquidity for future operations.
• The capital raise provides financial flexibility for future general corporate needs, including equity compensation, stock splits, financings, and potential strategic transactions.
• The Board has a structured corporate governance framework with a majority of independent directors (5 out of 9) and independent members on key committees (Audit, Compensation, Nominating and Corporate Governance), enhancing oversight.

Negatives

• Net loss significantly widened to $(51,409,000) in 2024 from $(18,721,000) in 2023 and $(16,515,000) in 2022, indicating a deteriorating financial performance trend.
• The proposed increase in authorized shares from 320,000,000 to 2,020,000,000, coupled with the Scilex warrant, will result in substantial dilution for existing stockholders.
• The issuance of 263,914,094 shares to Scilex upon exercise of the pre-funded warrant, combined with the initial 15,000,000 shares, represents a significant portion of outstanding common stock, potentially leading to Scilex having substantial influence over future company decisions.
• Executive compensation for Brett Moyer (CFO) and Gary Williams (former CAO) increased in 2024 despite the widening net loss, with compensation 'actually paid' to Mr. Moyer increasing from $365,884 in 2023 to $892,126 in 2024.

Risks

• Future issuance of additional authorized shares, including those from the Scilex warrant, may dilute earnings per share, equity, and voting rights of existing stockholders, potentially reducing the market price of common stock.
• The substantial increase in authorized shares could serve as an anti-takeover measure, potentially discouraging or delaying changes in control of the company.
• Scilex Holding Company, by beneficially owning a significant number of shares, could exert considerable influence over future company decisions, including the right to designate board directors.
• The issuance of Pre-Funded Warrant Shares to Scilex could be deemed a 'change of control' under Nasdaq Listing Rule 5635(b), requiring stockholder approval.

Future Outlook

The company aims to increase its authorized shares to provide greater flexibility for future general corporate needs, including equity compensation plans, stock splits, financings, and potential strategic transactions. The agreement with Scilex Holding Company includes a right for Scilex to participate in future debt or equity issuances up to 20% and to designate directors to the board based on its ownership percentage (two directors for >=10% ownership, one director for 5-10% ownership).

Management Comments

• The Board believes it is in the best interest of the Company to increase the number of authorized shares of capital stock to give the Company greater flexibility in considering and planning for future general corporate needs.
• The Board believes that additional authorized shares of Common Stock will enable the Company to take timely advantage of market conditions and favorable financing and acquisition opportunities.

Industry Context

The company operates in a technology-driven sector, likely involving AI and data vaulting, given its name. The significant capital raise through a pre-funded warrant and the use of Bitcoin as payment currency suggest an embrace of innovative financing methods, potentially reflecting challenges in traditional capital markets or a strategic alignment with digital asset trends. The need for a substantial share authorization increase points to a growth-oriented strategy that requires significant equity funding, common in high-growth tech sectors but also indicative of high capital burn rates.

Comparison to Industry Standards

• The widening net loss from $(16.5) million in 2022 to $(51.4) million in 2024 is a concerning trend, contrasting with many established tech companies that aim for profitability or reduced losses as they scale. For example, a mature SaaS company might target a net profit margin of 15-25%, while high-growth startups typically show a clearer path to profitability or decreasing losses.
• The proposed increase in authorized shares from 320 million to 2.02 billion is an exceptionally large increase, far exceeding typical share authorization requests from companies with similar market capitalizations, suggesting a very aggressive future capital raise strategy or significant dilution potential. For instance, a company like Palantir Technologies (PLTR) or C3.ai (AI) might issue shares for acquisitions or employee compensation, but a nearly 6-fold increase in authorized shares is uncommon without a major transformative event like a large merger.
• The issuance of a pre-funded warrant for 263.9 million shares to a single investor (Scilex) for $150 million in BTC is a substantial transaction, representing a significant portion of the company's current outstanding shares and indicating a potentially low effective share price for the capital raised. This type of financing, while providing capital, often comes with significant dilution that can be more pronounced than typical venture capital rounds or public offerings in more stable companies.
• The executive compensation structure, with significant equity incentives and increasing 'compensation actually paid' despite widening net losses, could be viewed critically compared to industry peers where compensation is more closely tied to positive financial performance metrics like revenue growth or profitability.

Management Changes

Corporate Governance

Legal Proceedings

• Brett Moyer served as a director of DionyMed Brands Inc., which was placed in receivership on October 29, 2019.
• Gary Williams served as chief financial officer of Quantum3D, Inc., which was placed into an assignment for the benefit of creditors in 2015.

Related Party Transactions

• Nathaniel Bradley (CEO) is a control person of EOS Technology Holdings Inc. (EOS), and his spouse, Sonia Choi, is CMO of both companies. At the EOS Closing (December 31, 2024), EOS received 3,999,911 shares of common stock.
• The Company owed EOS $10,000,000 under the EOS Note as of December 31, 2024, and $8,300,000 as of June 30, 2025. EOS owed the Company $431,000 in notes receivable as of December 31, 2024.
• The Company paid EOS $428,000 for transition services for the three months ended June 30, 2025, and $501,000 for the six months ended June 30, 2025.
• On September 7, 2025, EOS converted $3,200,000 of the EOS Note balance into 10,000,000 shares of Common Stock at $0.32 per share.
• Helge Kristensen (Director) is VP of Hansong Technology. Hansong Technology purchased modules from the Company for $58,000 (2024) and $88,000 (2023), and sold speaker products to the Company for $28,000 (2024) and $128,000 (2023). Balances were owed between the two entities.
• David Howitt (Director) is founder/CEO of Meriwether Group LLC, which owns 25% of Meriwether Group Capital Hero Fund LP. On September 8, 2023, the Company received a $650,000 term loan from Meriwether, which was repaid in full on December 7, 2023.

Stakeholder Impact

• **Shareholders:** Will experience significant dilution of their percentage ownership and voting rights if the proposed share increase and Scilex warrant issuance are approved and exercised. The market price of common stock could be adversely affected. However, the capital raise provides necessary funding for future operations and growth.
• **Management:** Executive officers' compensation includes significant equity incentives, aligning their interests with stock performance, though compensation increased despite widening net losses. New employment agreements for key executives like Brett Moyer include stay bonuses and severance provisions.
• **Employees:** The company's equity incentive plans (LTIP, 2020 Plan, Technical Team Retention Plan) are designed to attract and retain talent, potentially benefiting employees through stock awards. The transition services agreement with EOS also involves employees.
• **Scilex Holding Company:** Will become a major shareholder with significant influence over company decisions, including the right to designate board directors, following the full issuance of shares from the pre-funded warrant.
• **Creditors:** The capital raise from Scilex provides additional liquidity, potentially improving the company's ability to meet its financial obligations.

Next Steps

• Hold the Annual Meeting of Stockholders on November 24, 2025, to vote on the proposed matters.
• If approved, file a certificate of amendment to the Certificate of Incorporation to increase authorized shares.
• Upon stockholder approval, proceed with the Additional Closing to issue the Pre-Funded Warrant to Scilex Holding Company.
• The company is required to file a preliminary proxy statement for stockholder approval within 25 days of the Initial Closing Date (September 26, 2025) and hold a meeting within 75 days of the Initial Closing Date. If approval is not obtained, hold subsequent meetings every fourth month.

Key Dates

Recommendation

The company's financial performance shows a significantly widening net loss, from $(16.5) million in 2022 to $(51.4) million in 2024, indicating a deteriorating operational trend. The proposed massive increase in authorized shares (from 320 million to 2.02 billion) and the issuance of over 263 million shares to Scilex via a pre-funded warrant will lead to substantial dilution for existing shareholders. While the capital raise provides liquidity, the terms suggest a high cost of capital and the potential for significant downward pressure on the stock price due to the sheer volume of new shares. The increasing executive compensation despite worsening financial results also raises concerns about alignment with shareholder value. Given the severe dilution, worsening financial health, and potential for further stock price depreciation, a seasoned investor would likely recommend selling.

Keywords

Datavault AI, Scilex Holding Company, Proxy Statement, Share Increase, Authorized Shares, Pre-Funded Warrant, Stockholder Meeting, Corporate Governance, Dilution, Capital Raise, SEC Filing, Nasdaq Listing Rules, Bitcoin, Executive Compensation, Board of Directors